Coronavirus for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how COVID-19 affects people with cancer. Participants will complete a survey about their experiences during the pandemic. The trial seeks individuals with cancer who are 18 years or older and can provide verbal consent to participate. Those with cancer interested in sharing their experiences with COVID-19 might be a good fit for this study. As an unphased trial, this study offers a unique opportunity for patients to contribute valuable insights into the intersection of cancer and COVID-19.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on understanding how COVID-19 affects patients with cancer, a vital area that hasn't been fully explored. Unlike typical cancer treatments, which may involve chemotherapy, radiation, or immunotherapy, this study uses surveys to gather real-world data directly from patients. By analyzing this information, researchers aim to uncover patterns and insights into how COVID-19 impacts cancer patients specifically, potentially leading to better management strategies and support systems tailored to their unique needs during the pandemic.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Survey
Participants fill out an online survey regarding their experiences with COVID-19 and cancer care
Follow-up
Participants are monitored for additional insights through semi-structured telephone interviews
What Are the Treatments Tested in This Trial?
Interventions
- Survey
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor